Loading clinical trials...
Loading clinical trials...
Valbenazine in Obsessive-compulsive Disorder: A Randomized Double-blind Placebo-controlled Crossover Trial
Conditions
Interventions
Valbenazine
Placebo
Start Date
February 1, 2026
Primary Completion Date
December 1, 2027
Completion Date
December 1, 2027
Last Updated
February 5, 2026
NCT06647589
NCT04480918
NCT05623306
NCT07245134
NCT07232823
NCT04131829
Lead Sponsor
University of Chicago
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions